We have previously shown that VEGF, a pro-angiogenic factor, localises mainly in the stroma of HPV-positive head and neck cancers (3) and that HPV-positive cancer head and neck cancer cells can up-regulate programmed death ligands PD-L1 and PD-L2 on fibroblasts (4). Here, VEGFA is linked to head and neck cancer.